Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus

Original Article

K. Kabashima, T. Matsumura, H. Komazaki, and M. Kawashima

N Engl J Med 2020;383:141-150

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
07/08/2020
Course expires: 
07/09/2022

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Saturday, July 9, 2022 - 11:59pm.